Cboe (CBOE) Q2 2026 Earnings Call Transcript

Cboe Global Markets reported Q2 net revenue of $731.6 million (record), up 25% YoY, and adjusted diluted EPS of $3.56, up 45% YoY. The company raised 2026 total organic net revenue growth guidance to mid-to-high teens and reaffirmed adjusted operating expense guidance of $838 million–$853 million while increasing 2026 CapEx to $98 million–$108 million to support clearing infrastructure; it also launched Cboe Predicts and filed with the SEC for company-specific KPI (yes/no) contracts. Capital returns included $33 million of share repurchases (≈127,000 shares at $256.61 average) and a $0.72 per share dividend; overall tone remains constructive as flows in SPX 0DTE accelerated after the pattern day trader rule repeal.

Analysis

Cboe is becoming less of a pure fee-collector on listed options and more of a monetization engine for retail micro-trading intensity. The key second-order effect is that smaller ticket sizes and higher order frequency usually expand message traffic, data consumption, and clearing touchpoints faster than they expand headline notional, which is why the upside here is not just in options revenue but in Data Vantage, access fees, and future clearing economics. That also creates a structurally better backdrop for distribution partners like HOOD and SCHW, but Cboe owns the more durable tollbooth if product standardization wins.

The market may be underpricing the platform effect of event contracts: if these products become a habit-forming retail SKU, Cboe can pull through incremental engagement without needing a huge increase in directional risk appetite. The bigger competitive threat is not another exchange, but closed-stack brokers or prediction-market venues that try to keep order flow captive; those can win at low scale, but they struggle to match cross-margining, liquidity recycling, and institutional legitimacy. That makes the medium-term moat more about network effects than about any one product launch.

Risks are mostly regulatory and timing-driven over the next 1-3 months: SEC approval delays, comments that force redesign, or evidence that the post-rule-change retail burst is just a one-off. Over 6-18 months, the main falsifier is slower-than-expected conversion from curiosity to repeat trading, especially if volatility compresses or if semiannual reporting reduces event frequency enough to dent options impulse buying. Capex is moving up and buybacks will be moderated by the 2027 maturity, but the balance sheet is still ample enough that leverage is not the issue; execution and regulatory acceptance are.

Key Decisions for Investors

• Long CBOE on any 3-5% pullback over the next 1-2 weeks; thesis is multiple expansion on 2027 earnings power if retail engagement and product launches keep compounding. Falsifier: SPX 0DTE/mini-SPX volumes roll over for two consecutive months.
• Buy CBOE Jan-2027 call spreads rather than outright stock to express the KPI/event-contract optionality with limited downside. Risk/reward improves if SEC approval lands by late September; exit if approval slips into 2027.
• Pair trade: long CBOE / short SCHW for a cleaner monetization-vs-distribution spread. SCHW benefits from activity, but CBOE has higher revenue capture per incremental trade and more operating leverage to product breadth over the next 6-12 months.
• Keep HOOD on the watch list, not the core long: it should benefit from the same retail engagement wave, but it is more exposed to sentiment and product-mix noise. Better entry would be after confirmation that event contracts and 0DTE activity sustain into the fall.
• Do not chase NVDA or MSFT on this call; the KPI-contract angle is an option-like upside to their ecosystem, but there is no modeled revenue yet. Reassess only if SEC approval and broker distribution are clearly in hand.